Biased pathogenic assertions of loss of function variants challenge molecular diagnosis of admixed individuals
- 29 June 2021
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Vol. 187 (3) , 357-363
Abstract
Diagnosis of individuals affected by monogenic disorders was significantly improved by next‐generation sequencing targeting clinically relevant genes. Whole exomes yield a large number of variants that require several filtering steps, prioritization, and pathogenicity classification. Among the criteria recommended by ACMG, those that rely on population databases critically affect analyses of individuals with underrepresented ancestries. Population‐specific allelic frequencies need consideration when characterizing potential deleteriousness of variants. An orthogonal input for classification is annotation of variants previously classified as pathogenic as a criterion that provide supporting evidence widely sourced at ClinVar. We used a whole‐genome dataset from a census‐based cohort of 1,171 elderly individuals from São Paulo, Brazil, highly admixed, and unaffected by severe monogenic disorders, to investigate if pathogenic assertions in ClinVar are enriched with higher proportions of European ancestry, indicating bias. Potential loss of function (pLOF) variants were filtered from 4,250 genes associated with Mendelian disorders and annotated with ClinVar assertions. Over 1,800 single nucleotide pLOF variants were included, 381 had non‐benign assertions. Among carriers (N = 463), average European ancestry was significantly higher than noncarriers (N = 708; p = .011). pLOFs in genomic contexts of non‐European local ancestries were nearly three times less likely to have any ClinVar entry (OR = 0.353; p <.0001). Independent pathogenicity assertions are useful for variant classification in molecular diagnosis. However, European overrepresentation of assertions can promote distortions when classifying variants in non‐European individuals, even in admixed samples with a relatively high proportion of European ancestry. The investigation and deposit of clinically relevant findings of diverse populations is fundamental improve this scenario.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (465355/2014‐5)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2013/08028‐1, 2014/50649‐6, 2014/50931‐3)
- National Institute of General Medical Sciences (R01 GM075091)
This publication has 31 references indexed in Scilit:
- Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research ConsortiumThe American Journal of Human Genetics, 2016
- Clinical sequencing: is WGS the better WES?Human Genetics, 2016
- Distance from sub-Saharan Africa predicts mutational load in diverse human genomesProceedings of the National Academy of Sciences, 2015
- A global reference for human genetic variationNature, 2015
- Summarizing polygenic risks for complex diseases in a clinical whole-genome reportGenetics in Medicine, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- Haplotype Estimation Using Sequencing ReadsThe American Journal of Human Genetics, 2013
- The Next-Generation Sequencing Revolution and Its Impact on GenomicsCell, 2013
- RFMix: A Discriminative Modeling Approach for Rapid and Robust Local-Ancestry InferenceThe American Journal of Human Genetics, 2013
- A Systematic Survey of Loss-of-Function Variants in Human Protein-Coding GenesScience, 2012